Back to Clinical Feed
Try:
PLOS ONEResearch HighlightsOpen Access
Evaluation of the diagnostic value of the Modified Evan’s Blue Dye Test for assessing aspiration in tracheostomized critically ill patients: A systematic review and meta-analysis
13 May 20265 min read0 viewsJournal Feed
GIST (Key Takeaways)
- by Eszter Szőke, Ildikó Szántó, Caner Turan, Bence Szabó, Márton Papp, Gábor Horváth, László Zubek, Péter Hegyi, Zsolt Molnár, András Lovas Dysphagia and aspiration are common complications in tracheostomized critically ill patients. The Modified Evan’s Blue Dye Test (MEBDT) is a non-invasive, bedside, adjunctive rule-in signal for aspiration when positive.
- However, its diagnostic accuracy compared to the gold standard Fiberoptic Endoscopic Evaluation of Swallowing (FEES) in these patients remains unclear. We conducted a systematic review and meta-analysis to evaluate the diagnostic accuracy of the MEBDT for the detection of aspiration in tracheostomized critically ill patients.
- Study protocol was prospectively registered on PROSPERO (CRD:42023479920). A systematic search was performed across three databases (PubMed, Cochrane Central, and Embase), followed by a systematic screening process against predetermined selection criteria and included studies that provided data on the sensitivity and specificity of MEBDT versus FEES.
- The risk of bias and the level of evidence certainty in the included papers were assessed by the QUADAS-2 tool and GRADE approach respectively. Six out of 2227 screened studies were included.
Clinical Editorial
Summary
PLOS ONE (Medicine) published a clinical update in Research Highlights on 13 May 2026.
The item focuses on Evaluation of the diagnostic value of the Modified Evan’s Blue Dye Test for assessing aspiration in tracheostomized critically ill patients: A systematic review and meta-analysis.
Review the original article for the full source wording and details.
Source Reference
Read the full original publication from the source journal or publisher link below.
Related by Condition/Drug
PLOS ONERelated by Specialty
Long-term effects following prenatal cocaine exposure: A systematic review
Research Highlights • 26 Jun 2026
PLOS ONERelated by Specialty
Validation of the Bangla PHQ-4 in rural and urban community samples from Bangladesh
Research Highlights • 26 Jun 2026
BMJ OpenRelated by Specialty
Evolution of blood biomarkers reflective of brain tissue damage and inflammation in the perioperative course of intracerebral haemorrhage evacuation in a phase II proof-of-concept trial
Research Highlights • 25 Jun 2026
BMJ OpenRelated by Specialty
Strategies to increase medications for opioid use disorder in hospital settings in the USA: protocol for a scoping review
Research Highlights • 25 Jun 2026
PLOS MedRelated by Specialty
Association of armed conflict and global measles cases: A structural equation modeling analysis of 193 countries from 2000 to 2023
Research Highlights • 25 Jun 2026
PLOS MedRelated by Specialty
Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study
Research Highlights • 24 Jun 2026
Feed Metadata
Source
PLOS ONE (Medicine)
Category
Research Highlights
Published
13 May 2026
Feed Metadata
Source
PLOS ONE (Medicine)
Category
Research Highlights
Published
13 May 2026